For example, overexpression of CPT1A is related to poor clinical results for esophageal squamous cell carcinoma, while disruption of CPT1A may prevent tumor metastasis and anoikis resistance (8). This evidence concerns the gene CPT1A and esophageal squamous cell carcinoma.